Connection

Charles Bennett to Male

This is a "connection" page, showing publications Charles Bennett has written about Male.
Connection Strength

2.288
  1. End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia. PLoS One. 2020; 15(6):e0234541.
    View in: PubMed
    Score: 0.038
  2. End of an era for erythropoiesis-stimulating agents in oncology. Int J Cancer. 2020 05 15; 146(10):2829-2835.
    View in: PubMed
    Score: 0.037
  3. Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors. Cancer Med. 2019 05; 8(5):2233-2240.
    View in: PubMed
    Score: 0.035
  4. Fluoroquinolone-associated suicide. Eur J Intern Med. 2018 09; 55:e21-e22.
    View in: PubMed
    Score: 0.033
  5. Editorial Comment. Urology. 2018 08; 118:125-126.
    View in: PubMed
    Score: 0.033
  6. Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017 06; 13(6):e562-e573.
    View in: PubMed
    Score: 0.031
  7. What Have Patients Been Hearing From Providers Since the 2012 USPSTF Recommendation Against Routine Prostate Cancer Screening? Clin Genitourin Cancer. 2017 12; 15(6):e977-e985.
    View in: PubMed
    Score: 0.031
  8. Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. J Clin Oncol. 2017 Jun 10; 35(17):1945-1951.
    View in: PubMed
    Score: 0.031
  9. Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia. Br J Haematol. 2018 01; 180(2):301-304.
    View in: PubMed
    Score: 0.029
  10. Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system. Expert Opin Drug Saf. 2016 Aug; 15(8):1003-11.
    View in: PubMed
    Score: 0.029
  11. Time course and predictors of use of erectile dysfunction treatment in a Veterans Affairs medical center. Int J Impot Res. 2016 Sep; 28(5):167-71.
    View in: PubMed
    Score: 0.029
  12. Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks. Am J Manag Care. 2016 04; 22(4):242-8.
    View in: PubMed
    Score: 0.028
  13. Big data, thromboembolism, and immunoglobulin. Blood. 2016 Jan 14; 127(2):171-2.
    View in: PubMed
    Score: 0.028
  14. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplant. 2016 Feb; 51(2):277-82.
    View in: PubMed
    Score: 0.028
  15. Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know? Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1714-5.
    View in: PubMed
    Score: 0.027
  16. Screening for viral hepatitis prior to rituximab chemotherapy. Ann Hematol. 2016 Jan; 95(1):27-33.
    View in: PubMed
    Score: 0.027
  17. Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. 2015 Sep; 11(5):363-4.
    View in: PubMed
    Score: 0.027
  18. Population-Based Assessment of Determining Treatments for Prostate Cancer. JAMA Oncol. 2015 Apr; 1(1):67-8.
    View in: PubMed
    Score: 0.026
  19. Editorial comment. Urology. 2015 Feb; 85(2):413.
    View in: PubMed
    Score: 0.026
  20. Geography: an increasingly important variable in prostate cancer clinical trials. BJU Int. 2015 Jan; 115(1):2-3.
    View in: PubMed
    Score: 0.026
  21. Editorial comment. Urology. 2014 Nov; 84(5):1072.
    View in: PubMed
    Score: 0.026
  22. Editorial comment. Urology. 2015 Jan; 85(1):153-4.
    View in: PubMed
    Score: 0.026
  23. Editorial comment. Urology. 2014 Apr; 83(4):786-7.
    View in: PubMed
    Score: 0.025
  24. Editorial comment. Urology. 2014 Jan; 83(1):152-3; discussion 153.
    View in: PubMed
    Score: 0.024
  25. Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis. J Natl Cancer Inst. 2013 Aug 07; 105(15):1072-3.
    View in: PubMed
    Score: 0.024
  26. Editorial comment. Urology. 2013 Jul; 82(1):66.
    View in: PubMed
    Score: 0.023
  27. Vision insurance, eye care visits, and vision impairment among working-age adults in the United States. JAMA Ophthalmol. 2013 Apr; 131(4):499-506.
    View in: PubMed
    Score: 0.023
  28. Editorial comment. Urology. 2013 Jan; 81(1):154; author reply 154.
    View in: PubMed
    Score: 0.023
  29. Will newer anticoagulants improve therapy persistence? Arch Intern Med. 2012 Nov 26; 172(21):1689-90.
    View in: PubMed
    Score: 0.023
  30. Editorial comment. Urology. 2012 Sep; 80(3):563.
    View in: PubMed
    Score: 0.022
  31. Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med. 2012 Dec; 27(12):1697-703.
    View in: PubMed
    Score: 0.022
  32. Editorial comment. Urology. 2012 Jul; 80(1):168.
    View in: PubMed
    Score: 0.022
  33. A 56-year-old physician who underwent a PSA test. Arch Intern Med. 2012 Feb 27; 172(4):311.
    View in: PubMed
    Score: 0.021
  34. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer". Arch Intern Med. 2010 Aug 09; 170(15):1397-9.
    View in: PubMed
    Score: 0.019
  35. Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study. J Clin Oncol. 2010 May 20; 28(15):2571-6.
    View in: PubMed
    Score: 0.019
  36. Racial variations in care and outcomes for inpatient HIV-related pneumocystis pneumonia. J Health Care Poor Underserved. 2010 Feb; 21(1):318-33.
    View in: PubMed
    Score: 0.019
  37. Czech health two decades on from the Velvet Revolution. Lancet. 2010 Jan 16; 375(9710):179-81.
    View in: PubMed
    Score: 0.018
  38. Metastasis of genitourinary tumors to the head and neck region. Eur Arch Otorhinolaryngol. 2010 Feb; 267(2):273-9.
    View in: PubMed
    Score: 0.018
  39. Heeding our words: complexities of research among low-literacy populations. J Clin Oncol. 2009 Apr 20; 27(12):1938-40.
    View in: PubMed
    Score: 0.017
  40. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 May 14; 113(20):4834-40.
    View in: PubMed
    Score: 0.017
  41. Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care. 2009 Feb; 47(2):176-83.
    View in: PubMed
    Score: 0.017
  42. Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. 2008 Dec; 9(12):1166-72.
    View in: PubMed
    Score: 0.017
  43. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center. Cancer. 2008 Sep 15; 113(6):1446-52.
    View in: PubMed
    Score: 0.017
  44. Late-onset hereditary axonal neuropathies. Neurology. 2008 Jul 01; 71(1):14-20.
    View in: PubMed
    Score: 0.016
  45. Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med. 2008 Mar 24; 168(6):632-42.
    View in: PubMed
    Score: 0.016
  46. Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol. 2007 Sep 18; 50(12):1138-43.
    View in: PubMed
    Score: 0.016
  47. Cancer-associated neutropenic fever: clinical outcome and economic costs of emergency department care. Oncologist. 2007 Aug; 12(8):1019-26.
    View in: PubMed
    Score: 0.016
  48. Process evaluation in an intervention designed to improve rates of colorectal cancer screening in a VA medical center. Health Promot Pract. 2007 Jul; 8(3):273-81.
    View in: PubMed
    Score: 0.015
  49. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. 2007 Apr; 12(4):478-83.
    View in: PubMed
    Score: 0.015
  50. Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm. Chest. 2007 Feb; 131(2):489-96.
    View in: PubMed
    Score: 0.015
  51. In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome. Neurogenetics. 2007 Jan; 8(1):45-9.
    View in: PubMed
    Score: 0.015
  52. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. 2006 Dec; 135(5):642-50.
    View in: PubMed
    Score: 0.015
  53. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. 2006 Jul; 68(1):89-93.
    View in: PubMed
    Score: 0.014
  54. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. Cancer. 2006 May 01; 106(9):2051-7.
    View in: PubMed
    Score: 0.014
  55. Local perspective of the impact of the HIPAA privacy rule on research. Cancer. 2006 Jan 15; 106(2):474-9.
    View in: PubMed
    Score: 0.014
  56. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol. 2005 Dec 01; 23(34):8877-83.
    View in: PubMed
    Score: 0.014
  57. Caveat medicus: consequences of federal investigations of marketing activities of pharmaceutical suppliers of prostate cancer drugs. J Clin Oncol. 2005 Dec 01; 23(34):8894-905.
    View in: PubMed
    Score: 0.014
  58. Thrombotic thrombocytopenic purpura-2005. Semin Thromb Hemost. 2005 Dec; 31(6):611-4.
    View in: PubMed
    Score: 0.014
  59. Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care. 2005 Oct; 17(7):863-73.
    View in: PubMed
    Score: 0.014
  60. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood. 2005 Nov 15; 106(10):3343-7.
    View in: PubMed
    Score: 0.014
  61. Opportunities for disease state management in prostate cancer. Dis Manag. 2005 Aug; 8(4):235-44.
    View in: PubMed
    Score: 0.014
  62. Colorectal cancer screening among African-American and white male veterans. Am J Prev Med. 2005 Jun; 28(5):479-82.
    View in: PubMed
    Score: 0.013
  63. Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol. 2005 Mar 01; 23(7):1548-54.
    View in: PubMed
    Score: 0.013
  64. Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999. Chest. 2005 Jan; 127(1):205-12.
    View in: PubMed
    Score: 0.013
  65. Pharmacoeconomics of liposomal anthracycline therapy. Semin Oncol. 2004 Dec; 31(6 Suppl 13):191-5.
    View in: PubMed
    Score: 0.013
  66. Health literacy and patient knowledge in a Southern US HIV clinic. Int J STD AIDS. 2004 Nov; 15(11):747-52.
    View in: PubMed
    Score: 0.013
  67. Pure red-cell aplasia and epoetin therapy. N Engl J Med. 2004 Sep 30; 351(14):1403-8.
    View in: PubMed
    Score: 0.013
  68. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004 Sep 01; 22(17):3524-30.
    View in: PubMed
    Score: 0.013
  69. Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol. 2004 Jul 01; 22(13):2617-22.
    View in: PubMed
    Score: 0.013
  70. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance. Health Expect. 2004 Jun; 7(2):115-25.
    View in: PubMed
    Score: 0.012
  71. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. 2004 Jun; 3(1):31-7.
    View in: PubMed
    Score: 0.012
  72. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr. 2004 Feb 01; 35(2):120-5.
    View in: PubMed
    Score: 0.012
  73. US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. 2004 Feb; 125(2):548-56.
    View in: PubMed
    Score: 0.012
  74. Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke. 2004 Feb; 35(2):533-7.
    View in: PubMed
    Score: 0.012
  75. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med. 2004 Jan 01; 116(1):28-34.
    View in: PubMed
    Score: 0.012
  76. Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival. Clin Infect Dis. 2003 Dec 01; 37(11):1549-55.
    View in: PubMed
    Score: 0.012
  77. HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med. 2001 Sep; 16(9):583-9.
    View in: PubMed
    Score: 0.010
  78. Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform. 2021 May; 28(1).
    View in: PubMed
    Score: 0.010
  79. A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999-2015. Ann Epidemiol. 2021 07; 59:24-32.
    View in: PubMed
    Score: 0.010
  80. Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review. Urology. 2001 Apr; 57(4):727-32.
    View in: PubMed
    Score: 0.010
  81. Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validity. Urology. 2001 Feb; 57(2):275-80.
    View in: PubMed
    Score: 0.010
  82. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update. J Clin Oncol. 2021 04 10; 39(11):1274-1305.
    View in: PubMed
    Score: 0.010
  83. Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany. Cancer Invest. 2001; 19(2):107-13.
    View in: PubMed
    Score: 0.010
  84. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey. Eur J Cancer Care (Engl). 2021 Jan; 30(1):e13301.
    View in: PubMed
    Score: 0.010
  85. Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. Nat Commun. 2020 09 23; 11(1):4737.
    View in: PubMed
    Score: 0.010
  86. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project. J Clin Oncol. 2000 Aug; 18(15):2805-10.
    View in: PubMed
    Score: 0.010
  87. Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 2000 Aug; 162(2 Pt 1):393-8.
    View in: PubMed
    Score: 0.010
  88. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med. 2000 Jun 15; 342(24):1773-7.
    View in: PubMed
    Score: 0.009
  89. A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med. 2000 Apr; 161(4 Pt 1):1081-6.
    View in: PubMed
    Score: 0.009
  90. Cost analysis of filgrastim for the prevention of neutropenia in pediatric T-cell leukemia and advanced lymphoblastic lymphoma: a case for prospective economic analysis in cooperative group trials. Med Pediatr Oncol. 2000 Feb; 34(2):92-6.
    View in: PubMed
    Score: 0.009
  91. Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis. Cancer Causes Control. 2020 Mar; 31(3):209-220.
    View in: PubMed
    Score: 0.009
  92. The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology. Ann Oncol. 1999 Nov; 10(11):1355-9.
    View in: PubMed
    Score: 0.009
  93. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999 Sep; 24(5):555-60.
    View in: PubMed
    Score: 0.009
  94. Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Qual Life Res. 1999 Aug; 8(5):461-70.
    View in: PubMed
    Score: 0.009
  95. Racial variation in the use of laparoscopic cholecystectomy in the Department of Veterans Affairs medical system. J Am Coll Surg. 1999 Jun; 188(6):604-22.
    View in: PubMed
    Score: 0.009
  96. A multi-attribute model of prostate cancer patient's preferences for health states. Qual Life Res. 1999 May; 8(3):171-80.
    View in: PubMed
    Score: 0.009
  97. Diffusion of laparoscopic cholecystectomy in the Veterans Affairs health care system, 1991-1995. Eff Clin Pract. 1999 Mar-Apr; 2(2):49-55.
    View in: PubMed
    Score: 0.009
  98. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Oct; 37(10):2099-2108.
    View in: PubMed
    Score: 0.009
  99. Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol. 1998 Nov; 160(5):1765-9.
    View in: PubMed
    Score: 0.008
  100. The 2018 ISDE achalasia guidelines. Dis Esophagus. 2018 Sep 01; 31(9).
    View in: PubMed
    Score: 0.008
  101. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998 Sep; 16(9):3101-4.
    View in: PubMed
    Score: 0.008
  102. Prostate cancer patients' utilities for health states: how it looks depends on where you stand. Med Decis Making. 1998 Jul-Sep; 18(3):278-86.
    View in: PubMed
    Score: 0.008
  103. Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer. Clin Genitourin Cancer. 2018 08; 16(4):313-317.
    View in: PubMed
    Score: 0.008
  104. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998 Apr 01; 128(7):541-4.
    View in: PubMed
    Score: 0.008
  105. Cancer insurance policies in Japan and the United States. West J Med. 1998 Jan; 168(1):17-22.
    View in: PubMed
    Score: 0.008
  106. Gender differences in care for acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia. Womens Health Issues. 1998 Jan-Feb; 8(1):45-52.
    View in: PubMed
    Score: 0.008
  107. Variations in the use of prostate cancer staging tests: results from one NCCN Institution. Oncology (Williston Park). 1997 Nov; 11(11A):155-7.
    View in: PubMed
    Score: 0.008
  108. Variations in medical care for HIV-related Pneumocystis carinii pneumonia: a comparison of process and outcome at two hospitals. Chest. 1997 Aug; 112(2):398-405.
    View in: PubMed
    Score: 0.008
  109. Predicting in-hospital mortality of patients with AIDS-related Pneumocystis carinii pneumonia: an example of hierarchically optimal classification tree analysis. Stat Med. 1997 Jul 15; 16(13):1451-63.
    View in: PubMed
    Score: 0.008
  110. Gender differences in early suspicion of tuberculosis in hospitalized, high-risk patients during 4 epidemic years, 1987 to 1990. Infect Control Hosp Epidemiol. 1997 Apr; 18(4):237-43.
    View in: PubMed
    Score: 0.008
  111. Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs. Urology. 1997 Feb; 49(2):218-24.
    View in: PubMed
    Score: 0.008
  112. A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians. Eur Urol. 1997; 32 Suppl 3:86-8.
    View in: PubMed
    Score: 0.007
  113. The effect of ethnicity on ICU use and DNR orders in hospitalized AIDS patients. J Clin Ethics. 1997; 8(2):150-7.
    View in: PubMed
    Score: 0.007
  114. Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15; 13(5):408-15.
    View in: PubMed
    Score: 0.007
  115. U.S. hospital care for HIV-infected persons and the role of public, private, and Veterans Administration hospitals. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15; 13(5):416-21.
    View in: PubMed
    Score: 0.007
  116. Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years. J Oncol Pract. 2016 06; 12(6):e670-80.
    View in: PubMed
    Score: 0.007
  117. Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer. 1996 May 01; 77(9):1854-61.
    View in: PubMed
    Score: 0.007
  118. Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Sep; 51(9):1228-32.
    View in: PubMed
    Score: 0.007
  119. Performance measurement in prostate cancer care: beyond report cards. Urology. 1996 Mar; 47(3):356-65.
    View in: PubMed
    Score: 0.007
  120. Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med. 1995 Aug 7-21; 155(15):1586-92.
    View in: PubMed
    Score: 0.007
  121. Patterns of care for and outcomes of Pneumocystis carinii pneumonia among persons with transfusion-acquired AIDS. Transfusion. 1995 Aug; 35(8):674-8.
    View in: PubMed
    Score: 0.007
  122. Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami: 1987-1990. J Infect Dis. 1995 Jul; 172(1):312-5.
    View in: PubMed
    Score: 0.007
  123. Editorial Comment. Urology. 2015 Jul; 86(1):78.
    View in: PubMed
    Score: 0.007
  124. Poor responder to plasma exchange therapy in acquired thrombotic thrombocytopenic purpura is associated with ADAMTS13 inhibitor boosting: visualization of an ADAMTS13 inhibitor complex and its proteolytic clearance from plasma. Transfusion. 2015 Oct; 55(10):2321-30.
    View in: PubMed
    Score: 0.007
  125. High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy? Ann Oncol. 2015 Jul; 26(7):1390-5.
    View in: PubMed
    Score: 0.007
  126. Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer. Urology. 1995 Apr; 45(4):633-40.
    View in: PubMed
    Score: 0.007
  127. The learning curve for AIDS-related Pneumocystis carinii pneumonia: experience from 3,981 cases in Veterans Affairs Hospitals 1987-1991. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 01; 8(4):373-8.
    View in: PubMed
    Score: 0.007
  128. Barriers to condom use and needle cleaning among impoverished minority female injection drug users and partners of injection drug users. Public Health Rep. 1995 Mar-Apr; 110(2):166-72.
    View in: PubMed
    Score: 0.007
  129. Sustaining mammography screening among the medically underserved: a follow-up evaluation. J Womens Health (Larchmt). 2015 Apr; 24(4):291-8.
    View in: PubMed
    Score: 0.007
  130. Costs of terminal care for people with AIDS. AIDS Patient Care. 1995 Feb; 9(1):7-9.
    View in: PubMed
    Score: 0.007
  131. Informal caregivers of persons with AIDS. J Palliat Care. 1995; 11(2):10-8.
    View in: PubMed
    Score: 0.007
  132. A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1994 Dec; 150(6 Pt 1):1503-7.
    View in: PubMed
    Score: 0.006
  133. The association between race and treatment regret among men with recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2015 Mar; 18(1):38-42.
    View in: PubMed
    Score: 0.006
  134. Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. 2014 Oct 20; 32(30):3436-48.
    View in: PubMed
    Score: 0.006
  135. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. 2014 Mar-Apr; 12(2):121-7.
    View in: PubMed
    Score: 0.006
  136. Cross-sectional analysis of Met235-->Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun. 1993 Dec 15; 197(2):833-9.
    View in: PubMed
    Score: 0.006
  137. Erythropoietin, a novel repurposed drug: an innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen. 2014 Jan-Feb; 22(1):23-33.
    View in: PubMed
    Score: 0.006
  138. Strategies to improve repeat fecal occult blood testing cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):134-43.
    View in: PubMed
    Score: 0.006
  139. Improving colon cancer screening in community clinics. Cancer. 2013 Nov 01; 119(21):3879-86.
    View in: PubMed
    Score: 0.006
  140. Angiotensin receptor blockers: are they related to lung cancer? J Hypertens. 2013 Aug; 31(8):1669-75.
    View in: PubMed
    Score: 0.006
  141. The utility of prostate-specific antigen in the management of advanced prostate cancer. BJU Int. 2013 Sep; 112(5):548-60.
    View in: PubMed
    Score: 0.006
  142. Reply to S.P.Sura et al. J Clin Oncol. 2013 Jul 01; 31(19):2512.
    View in: PubMed
    Score: 0.006
  143. Angiotensin receptor blockers and risk of prostate cancer among United States veterans. J Clin Pharmacol. 2013 Jul; 53(7):773-8.
    View in: PubMed
    Score: 0.006
  144. Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. 2014 Jan; 32(1):26.e25-31.
    View in: PubMed
    Score: 0.006
  145. Outcomes of specialized and traditional AIDS counseling programs for impoverished women of color. Res Nurs Health. 1993 Feb; 16(1):11-21.
    View in: PubMed
    Score: 0.006
  146. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology. 2013 Jan; 81(1):130-4.
    View in: PubMed
    Score: 0.006
  147. Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol. 2012 Nov 10; 30(32):3947-52.
    View in: PubMed
    Score: 0.006
  148. Health care use by human immunodeficiency virus-infected students at a California student health service. West J Med. 1992 Jul; 157(1):41-3.
    View in: PubMed
    Score: 0.005
  149. Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. PLoS One. 2012; 7(3):e33029.
    View in: PubMed
    Score: 0.005
  150. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease. Ann Intern Med. 1992 Feb 01; 116(3):177-82.
    View in: PubMed
    Score: 0.005
  151. Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1992; 5(9):856-64.
    View in: PubMed
    Score: 0.005
  152. Medical care costs of intravenous drug users with AIDS in Brooklyn. J Acquir Immune Defic Syndr (1988). 1992; 5(1):1-6.
    View in: PubMed
    Score: 0.005
  153. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int. 2012 Jul; 110(2):201-5.
    View in: PubMed
    Score: 0.005
  154. Patterns of care related to age of men with prostate cancer. Cancer. 1991 May 15; 67(10):2633-41.
    View in: PubMed
    Score: 0.005
  155. The relation between resource use and in-hospital mortality for patients with acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia. Arch Intern Med. 1990 Jul; 150(7):1447-52.
    View in: PubMed
    Score: 0.005
  156. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica. 2010 Sep; 95(9):1555-62.
    View in: PubMed
    Score: 0.005
  157. Feasibility and effectiveness of the NEST13+ as a screening tool for advanced illness care needs. J Palliat Med. 2010 Feb; 13(2):161-9.
    View in: PubMed
    Score: 0.005
  158. Evaluation of a potential clinical interaction between ceftriaxone and calcium. Antimicrob Agents Chemother. 2010 Apr; 54(4):1534-40.
    View in: PubMed
    Score: 0.005
  159. The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. Urology. 2010 Mar; 75(3):623-9.
    View in: PubMed
    Score: 0.004
  160. The relation between hospital experience and in-hospital mortality for patients with AIDS-related PCP. JAMA. 1989 May 26; 261(20):2975-9.
    View in: PubMed
    Score: 0.004
  161. Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack. Intern Med J. 2010 Apr; 40(4):275-80.
    View in: PubMed
    Score: 0.004
  162. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009 Jan; 249(1):63-71.
    View in: PubMed
    Score: 0.004
  163. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008 Mar 01; 27(5):412-21.
    View in: PubMed
    Score: 0.004
  164. Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol. 2007 Nov 20; 25(33):5248-53.
    View in: PubMed
    Score: 0.004
  165. Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care. 2007 Nov; 45(11):1026-33.
    View in: PubMed
    Score: 0.004
  166. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007 May 09; 297(18):1992-2000.
    View in: PubMed
    Score: 0.004
  167. G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol. 2007 Jun; 137(6):545-52.
    View in: PubMed
    Score: 0.004
  168. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2007 Apr 20; 25(12):1596-605.
    View in: PubMed
    Score: 0.004
  169. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9.
    View in: PubMed
    Score: 0.004
  170. Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferon. Am J Med. 1986 Dec; 81(6):1065-7.
    View in: PubMed
    Score: 0.004
  171. Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007 Feb; 65(2):253-60.
    View in: PubMed
    Score: 0.004
  172. Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat Rep. 1986 Sep; 70(9):1081-4.
    View in: PubMed
    Score: 0.004
  173. Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006 Aug; 21(8):847-51.
    View in: PubMed
    Score: 0.004
  174. Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006 May; 20(5):359-68.
    View in: PubMed
    Score: 0.004
  175. Staging and therapy of orbital lymphomas. Cancer. 1986 Mar 15; 57(6):1204-8.
    View in: PubMed
    Score: 0.004
  176. A qualitative study of literacy and patient response to HIV medication adherence questionnaires. J Health Commun. 2005 Sep; 10(6):509-17.
    View in: PubMed
    Score: 0.003
  177. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer. 2005 Jun; 4(1):15-23.
    View in: PubMed
    Score: 0.003
  178. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005 May; 79(5):1698-703.
    View in: PubMed
    Score: 0.003
  179. Development of a brief survey on colon cancer screening knowledge and attitudes among veterans. Prev Chronic Dis. 2005 Apr; 2(2):A11.
    View in: PubMed
    Score: 0.003
  180. Genotyping and functional analysis of the D104N variant of human endostatin. Cancer Biol Ther. 2004 Dec; 3(12):1298-303.
    View in: PubMed
    Score: 0.003
  181. American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol. 2004 Jul 15; 22(14):2927-41.
    View in: PubMed
    Score: 0.003
  182. HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. 2004 Feb; 18(2):99-107.
    View in: PubMed
    Score: 0.003
  183. Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest. 2004; 22(2):225-33.
    View in: PubMed
    Score: 0.003
  184. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003 Oct; 134(4):720-7; discussion 727-9.
    View in: PubMed
    Score: 0.003
  185. Increased incidence of renal parenchymal carcinoma in the Northern and Yorkshire region of England, 1978-1997. Eur J Cancer. 2003 May; 39(7):961-7.
    View in: PubMed
    Score: 0.003
  186. A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest. 2003 Apr; 123(4):1151-60.
    View in: PubMed
    Score: 0.003
  187. Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol. 2003 Feb; 15(2):60-2.
    View in: PubMed
    Score: 0.003
  188. Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. 2003 Jan; 61(1):172-8.
    View in: PubMed
    Score: 0.003
  189. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients. Clin Prostate Cancer. 2002 Sep; 1(2):105-14.
    View in: PubMed
    Score: 0.003
  190. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. 2002 Jul 15; 95(2):361-76.
    View in: PubMed
    Score: 0.003
  191. Testicular health awareness in pubertal males. J Urol. 2000 Sep; 164(3 Pt 2):1115-7.
    View in: PubMed
    Score: 0.002
  192. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000 Jul; 164(1):214-8.
    View in: PubMed
    Score: 0.002
  193. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med. 2000 Apr 04; 132(7):566-77.
    View in: PubMed
    Score: 0.002
  194. Maximal androgen blockade for advanced prostate cancer. Cochrane Database Syst Rev. 2000; (2):CD001526.
    View in: PubMed
    Score: 0.002
  195. Comparative study of the clinical efficacy of two dosing regimens of flutamide. Mol Urol. 2000; 4(3):259-63;discussion 265.
    View in: PubMed
    Score: 0.002
  196. Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center 1989 to 1995. Bone Marrow Transplant. 1999 Sep; 24(6):679-84.
    View in: PubMed
    Score: 0.002
  197. QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology (Williston Park). 1999 Jun; 13(6):823-32; discussion 835-8.
    View in: PubMed
    Score: 0.002
  198. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Evid Rep Technol Assess (Summ). 1999 May; (4):i-x, 1-246, I1-36, passim.
    View in: PubMed
    Score: 0.002
  199. Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med. 1998 Apr; 26(4):668-75.
    View in: PubMed
    Score: 0.002
  200. Performance measurement in pneumonia care: beyond report cards. Mayo Clin Proc. 1998 Jan; 73(1):5-9.
    View in: PubMed
    Score: 0.002
  201. Comparison of perspectives on prostate cancer: analyses of survey data. Urology. 1997 Sep; 50(3):366-72.
    View in: PubMed
    Score: 0.002
  202. Approaches to prostate cancer by managed care organizations. Urology. 1997 Jul; 50(1):79-86.
    View in: PubMed
    Score: 0.002
  203. Predictors of resource utilization for hospitalized patients with Pneumocystis carinii pneumonia (PCP): a summary of effects from the multi-city study of quality of PCP care. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 01; 12(4):379-85.
    View in: PubMed
    Score: 0.002
  204. Self-perceived unmet health care needs of persons enrolled in HIV care. J Community Health. 1996 Jun; 21(3):183-98.
    View in: PubMed
    Score: 0.002
  205. The impact of housing status on health care utilization among persons with HIV disease. J Health Care Poor Underserved. 1996; 7(1):36-49.
    View in: PubMed
    Score: 0.002
  206. Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med. 1995 Nov; 152(5 Pt 1):1435-42.
    View in: PubMed
    Score: 0.002
  207. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users. AIDS Res Hum Retroviruses. 1993 Oct; 9(10):1043-50.
    View in: PubMed
    Score: 0.001
  208. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr (1988). 1993 Jun; 6(6):617-23.
    View in: PubMed
    Score: 0.001
  209. A prospective study of complications in Hickman right-atrial catheters in marrow transplant patients. JPEN J Parenter Enteral Nutr. 1990 Jan-Feb; 14(1):27-30.
    View in: PubMed
    Score: 0.001
  210. Evaluating institutional performance in AIDS-associated Pneumocystis carinii pneumonia: a risk adjustment approach. J Clin Epidemiol. 1989; 42(5):421-5.
    View in: PubMed
    Score: 0.001
  211. Patterns of gallium-67 scintigraphy in patients with acquired immunodeficiency syndrome and the AIDS related complex. J Nucl Med. 1987 Jul; 28(7):1103-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.